Fri, Jan. 23, 8:27 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales growth of 3% in Q4.
- Segment revenue: Personal care: $2.34B (-1.3%); Consumer Tissue: $1.62B (-2.82%); K-C Professional: $857M (+1.3%).
- Segment operating profit: Personal care: $410M (+3.02%); Consumer Tissue: $280M (+1.82%); K-C Professional: $151M (+2.03%).
- FY2015 Guidance: Organic sales growth: 3% to 5%; Volume : +2% to +3%; Adjusted operating profit: +1% to +4%; Tax rate: 31.5% to 33.5%; Adjusted EPS: $5.60 to $5.80 (+2% to +5%); Capital expenditure: $950M to $1.05B.
- KMB -4.04% premarket.
Fri, Jan. 23, 7:33 AM
Thu, Jan. 22, 5:30 PM
Fri, Jan. 9, 10:24 AM
Dec. 23, 2014, 9:35 AM| Comment!
Nov. 14, 2014, 10:38 AM
- Dow Chemical (DOW +1%) says it "fundamentally disagrees" with the position outlined by Dan Loeb's Third Point hedge fund in its latest statement and new website, which the company says reflect the views of "an activist investor that has little interest in anything that benefits [Dow's] many long-term shareholders."
- Jim Cramer is now a fan of Dow, citing the company as an example of a buyback done right; combining Dow's $5B increase in its buyback plan with its total repurchase authorization totals ~17% of market cap.
- Cramer also sees buyback opportunities in FLEX, JACK, M, DIS, KMB, VIA, DPS and AZN.
Nov. 13, 2014, 2:59 PM
Nov. 13, 2014, 2:35 PM
Nov. 8, 2014, 9:25 AM
- Energy companies finally are starting to halt a few new U.S. drilling projects as oil prices fall, which Barclays believes may put the U.S. oil boom at risk but "on balance, we believe lower oil prices are good.”
- If strong U.S. energy growth is interrupted, spending in the sector could be cut by $40B, but consumers could save $70B next year as the price at the pump falls for gasoline and diesel, according to Barclays head of U.S. equity strategy Jonathan Glionna.
- The most likely beneficiaries would be discretionary areas such as restaurants, entertainment, apparel, electronics and furniture, he says.
- Glionna lists 27 stocks that could benefit from lower oil prices: AAL, AGCO, AXL, BERY, BLMN, BWLD, CHH, CLX, DE, DPZ, FDX, GM, HD, KMB, KR, KSS, MHK, MMM, PENN, PPG, SAVE, SHW, TGT, UPS, VAL, WMS, WMT.
Nov. 3, 2014, 10:51 AM| Comment!
Oct. 21, 2014, 9:18 AM
- Kimberly-Clark (NYSE:KMB) announces it will restructure itself in order to improve efficiency following the spinoff of its health care operation.
- The company's workforce will be reduced by 1,100 to 1,300 employees.
- Total costs for the restructuring are pegged at $130M-$160M.
- The action is expected to deliver pre-tax savings of $120M-$140M by the end of 2017.
- Previous: Q3 results, highlights.
- KMB +0.9% premarket.
Oct. 21, 2014, 9:11 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales 4% in Q3 with all segments showing a volume gain.
- Segment revenue growth: Personal care +3.9% to $2.475B, Consumer Tissue +4.4% to $1.697B, K-C Professional +3.6% to $873M, Health Care -2.7% to $392M.
- Guidance: The company sets its outlook for FY14 EPS at $5.93-$6.03 vs. $6.00-$6.15 prior and $6.06 consensus.
- KMB +0.9% premarket
Oct. 21, 2014, 7:31 AM
Oct. 20, 2014, 5:30 PM
Oct. 7, 2014, 9:04 AM
- Kimberly-Clark (NYSE:KMB) indicates shareholders will receive one share of Halyard Health common stock for every 8 shares of common stock they own.
- The spinoff of the healthcare business will occur on October 31.
- As a result of a cash payment incoming from Halyard Health, Kimberly-Clark ups its share repurchase target for the current year to $2B from $1.3B-$1.5B.
Sep. 22, 2014, 12:00 PM
- Citigroup analyst Wendy Nicholson thinks a takeover by Procter & Gamble (PG +0.5%) or Unilever (UL -0.1%) of Clorox makes little sense due to the heavy concentration of the multinational in developed markets.
- Nicholson thinks a more logical choice would be Kimberly Clark (KMB +0.4%) due to its size and corporate personality, although she is quick to note that even a KMB bid looks unlikely with valuation stretched out on Clorox and limited cost-slashing opportunities lying in wait.
KMB vs. ETF Alternatives
Other News & PR